_________________
April 4, 2023 | ValGenesis and ProQuality Network are helping companies evaluate digital transformation solutions in line with Pharma 4.0 requirements with special focus on quality and compliance.
ValGenesis News
ValGenesis and ProQuality Network are helping companies evaluate digital transformation solutions in line with Pharma 4.0 requirements with special focus on quality and compliance.
ValGenesis Design Manager, a new module within VLMS 4.2 that is ready for computer software assurance (CSA) out of the box. As a new module within VLMS 4.2, Design Manager enables any company to develop risk-based requirements and apply critical thinking to validation processes.
ValGenesis, Inc., the market leader in enterprise validation lifecycle management solutions, announced that Continuus Pharmaceuticals, an end-to-end integrated continuous manufacturing (ICM) company, successfully went live with the ValGenesis Validation Lifecycle Management System (VLMS) to efficiently manage validation processes across the company as 100% digital.
The strategic alliance will offer global pharmaceutical companies a streamlined, software-based solution to enhance quality assurance across their global supply chains.
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and Enterey, a specialist life sciences consulting company, have partnered to deliver Pharma 4.0-focused digital transformation services and solutions for life sciences companies across the U.S.
ValGenesis and Scignyte provide an integrated governance approach with streamlined collaboration and data integrity, further strengthening risk and compliance across R&D processes.
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced that a leading pharmaceutical manufacturer selected ValGenesis VLMS to digitize multiple validation processes across the organization after a rigorous audit of possible solutions.
In this partnership, QualiTech will implement and manage next-generation digital validation tools developed by ValGenesis, enabling clients to further strengthen risk and compliance across the GMP lifecycle.
“Digitizing validation processes is crucial for compliance-focused life sciences companies to be able to meet stringent global regulatory requirements,” says Dr. Siva Samy, CEO & Chief Product Strategist at ValGenesis.
ValGenesis, Inc and Orbis LabSystems have partnered to deliver best-in-class digital validation solutions for life science companies across Europe, with a focus on Ireland.